Coherus BioSciences Inc. News
Can This Small-Cap Biotech 5x Revenue by 2026?
It has one product on the market and up to four more launching by the end of 2023. The growth trajectory depends on execution.
FDA Approves Coherus' Version of Abbvie's Humira, Best-Selling Drug in the U.S.
Coherus was cleared by the FDA for a drug that's similar to AbbVie's Humira. Coherus plans to launch the psoriasis treatment in July 2023.
Five Below, Splunk, Snap: 'Mad Money' Lightning Round
Jim Cramer weighs in on Five Below, Splunk, Snap, Crown Castle, Square, 3D Systems, Dana, Alibaba, Coherus Biosciences.
The One-and-Wait Plan: Cramer's 'Mad Money' Recap
Jim Cramer's got a plan: Fed Chairman Jay Powell should hike once, then wait -- and maintain the independence of the Fed.
Five Rules For This Market Beast: Cramer's 'Mad Money' Recap (Tues 1/16/18)
Even with Monday's sharp reversal, Jim Cramer says he still likes this market.
Biotech Movers: Acceleron, Clovis, Coherus
Acceleron Pharma, Clovis Oncology and Coherus BioSciences premarket trading on Tuesday.
Biotech Movers: Coherus, XBiotech, Flexion
Coherus BioSciences, XBiotech and Flexion Therapeutics were among the biotech stock movers in premarket trading on Monday.
AbbVie Stock Lower on Humira Patent Ruling
The drug is responsible for more than 60% of AbbVie's top line.
Here's what blackstone bought and sold in the fourth quarter
Private equity firms' publicly traded equity holdings are a valuable source of ideas for growth and value investors, alike.
AbbVie stock higher on Humira patent win
The Patent Trial and Appeal Board has denied Coherus's petition to make a copy of AbbVie's Humira drug.
Breaking News
Disney Makes Morningstar List of Top Communications Stocks
Communications stocks have suffered recently from a slowing economy, creating buying opportunities.
Credit-Score Errors Hit Consumers; Here's How to Lift and Fix Your Score
Why are so many Americans having issues with their credit scores? Here's why -- and what to do if you need to build up your credit score.
A Major Change Is Coming to Wall Street and Corporate America
The Democrats have just pulled off an unprecedented coup that will displease investors and financiers.
Disney Cruise Lines Makes a Major Family-Friendly Change
This may make it easier for you to sail with your kids.